Duquesne University, Applied Isotope Technologies Sign Research Agreement
Duquesne University, in its latest research agreement with a biotechnology company, is working to develop and improve products for environmental and biomedical analyses.
Through this agreement with Pittsburgh-based Applied Isotope Technologies Inc. (AIT), an additional post-doctoral research position will be funded at Duquesne. “The arrangement will allow AIT’s research to advance more quickly, provide opportunities for Duquesne faculty and students in areas that have practical commercial or industrial applications, and help to create jobs in the community,” said Dr. Alan Seadler, the Edward V. Fritzky Chair in Biotechnology Leadership and director of the Center for Biotechnology at Duquesne.
“Often, research will end up only being published in a paper. It’s when we go from bench top to bedside that the public begins to see the value of what we create here,” said Seadler, a former CEO of a biotechnology company.
This and future similar agreements will strengthen collaboration among the University’s scientific schools and its schools of business and law, Seadler said. Students could gain internship possibilities with growing companies, and the community as a whole could benefit from a potential increase in jobs.
“This research agreement represents one additional way in which Duquesne is participating in economic development through technology transfer and start-up companies,” added Dr. Heinz W. Machatzke, associate academic vice president of research.
The research results could be used in laboratory and U.S. Department of Homeland Security applications to measure minute amounts of materials, particularly metals, in biomedical or environmental samples, and determine if problems exist with contamination and toxicity. The technology could have other health applications, such as detecting indicators of cancers.
“We are pleased and excited about the collaborative path we have embarked on with Duquesne,” said Matt Pamuku, chief executive officer and president of AIT. “By enabling scientists to accurately measure the tiniest but functionally critical molecular compounds, this and future research agreements will answer some of the most puzzling scientific questions and unlock many secrets of nature, thereby helping preserve and extend quality of life.”
The method to accurately determine measurement of minute samples was developed by Dr. H.M. “Skip” Kingston, a chemistry professor in Duquesne’s Bayer School of Natural and Environmental Sciences, whose methods prompted the launching of AIT in 2003. The company continues to develop new measurement methods, standards and services important to the biochemical and biomedical fields.
The research associated with this agreement is funded through a grant to AIT from Pittsburgh Life Sciences Greenhouse, an economic development initiative formed to accelerate Western Pennsylvania's life sciences industry.
Applied Isotope Technologies Inc.
Applied Isotope Technologies Inc., (AIT) is a company developing products, methods, and services for the environmental and biological markets. Founded in 2003, AIT is developing new measurement methods, standards and services to meet the needs for accurately determining chemicals and biological markers that will result in tools for early diagnosis of human disease. For more information on the company, please check www.SIDMS.com, call 408.472.2333 or e-mail info@SIDMS.com.
Founded in 1878, Duquesne is consistently ranked among the nation's top Catholic universities for its award-winning faculty and tradition of academic excellence. Duquesne, a campus of nearly 9,500 graduate and undergraduate students, has been nationally recognized for its academic programs, community service and commitment to sustainability. Follow Duquesne University on Facebook, Twitter and Instagram.